AUSN

SUMMER 2017

Navy magazine is distributed on Capitol Hill,the Pentagon and naval bases around the world. It provides information that impacts Sailors, their families and the Navy. Navy is published quarterly by the Association of the United States Navy (AUSN).

Issue link: http://digital.ausn.org/i/873128

Contents of this Issue

Navigation

Page 14 of 51

Shipmates' Symposium 13 Association of the United States Navy MC2 FELICITO RUSTIQUE; VETERANS AFFAIRS monitors will automatically record electroencephalograms (EEGs) outside the clinic environment. Nanotechnology is bringing materials and devices that are one billionth the size of a meter into modern medical applications, and not just devices. Drugs and pharmaceuticals can be delivered via nanotechnology. Vaccines can be completely needle-less. Surgery and diagnostics including imaging are now via nanotech- nology. Hemorrhage control, wound management and actual regeneration of tissue can be aided, for example, via the use of chitosan - silver nanoparticles and copper. Chitosan is a derivative of chitin, which is found in the exoskeletons of insects. Carbon nanotubes are also being researched by the VA and DoD health care systems for use in bone tissue engineering. From performing research into these medical technology options, some of the results of applying microelectronics and nanotechnology in patient treat- ment include decreasing toxic side effects from current treatment modalities, improving patient compliance, and reducing dosage over time. For active duty, Selected Reserve, Individual Ready Reserve, retirees, disabled veterans and wounded returning military members, these are all amazing developments bound to improve military, veterans and civilian health care systems in what they will be able to offer their customers. Marylynn Marrese, Ph.D., CAPT, MSC, USN (Ret.), is AUSN's Director of Military and Veterans Benefits. Recently, the VA purchased 28 additional ReWalk Personal Exo- skeleton Systems to support an ongoing national clinical trial. The study—which is the first of its kind in the United States—examines the impact of exoskeleton use in a personal setting, with the goal of advancing care for Veterans with spinal cord injury. HM2 Patrick Malveda simulates a computed tomography head scan with intravenous contrast for training purposes in the radiology department at U.S. Naval Hospital Naples. Nasal absorption enhancer for peptide drugs siRNA/DNA delivery for gene therapy Chemotherapeutic delivery Adjuvant for vaccine in immunotherapy Scaffold engineering/ Wound healing Chitosan

Articles in this issue

Archives of this issue

view archives of AUSN - SUMMER 2017